変形性関節症疼痛治療剤のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Osteoarthritis Pain Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16275 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

変形性関節症疼痛治療剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の変形性関節症疼痛治療剤の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の変形性関節症疼痛治療剤の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 変形性関節症疼痛治療剤市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・経口、注射、外用 用途別セグメントは次のように区分されます。 ・医療、パーソナルケア 世界の変形性関節症疼痛治療剤市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Bayer、SK Chemicals、GSK、Sanofi、Crystal Genomics、Johnson & Johnson、Sino Biopharmaceutical、Haohai Biological、Zhejiang Chengyi Pharmaceutical、Freda、Bright Future、Jingfeng Pharmaceutical、Chugai Pharmaceutical、Mikasa Seiyaku、Taisho Pharmaceutical、Seikagaku Corporation、GlaxoSmithKline、Eli Lilly、Novartis、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、変形性関節症疼痛治療剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な変形性関節症疼痛治療剤メーカーの企業概要、2019年～2021年までの変形性関節症疼痛治療剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な変形性関節症疼痛治療剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別変形性関節症疼痛治療剤の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの変形性関節症疼痛治療剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での変形性関節症疼痛治療剤市場予測を収録しています。 ・第12、13、14章では、変形性関節症疼痛治療剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Bayer、SK Chemicals、GSK、Sanofi、Crystal Genomics、Johnson & Johnson、Sino Biopharmaceutical、Haohai Biological、Zhejiang Chengyi Pharmaceutical、Freda、Bright Future、Jingfeng Pharmaceutical、Chugai Pharmaceutical、Mikasa Seiyaku、Taisho Pharmaceutical、Seikagaku Corporation、GlaxoSmithKline、Eli Lilly、Novartis、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、外用 ・用途別分析2016年-2026年：医療、パーソナルケア ・変形性関節症疼痛治療剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・変形性関節症疼痛治療剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・変形性関節症疼痛治療剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・変形性関節症疼痛治療剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・変形性関節症疼痛治療剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Osteoarthritis Pain Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Osteoarthritis Pain Drugs size is estimated to be XX million in 2021 from USD 9505.4 million in 2020, with a change of XX% between 2020 and 2021. The global Osteoarthritis Pain Drugs market size is expected to grow at a CAGR of 5.5% for the next five years.

Market segmentation
Osteoarthritis Pain Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Injection
External

Market segment by Application can be divided into
Medical Care
Personal Care

The key market players for global Osteoarthritis Pain Drugs market are listed below:
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Osteoarthritis Pain Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Osteoarthritis Pain Drugs, with price, sales, revenue and global market share of Osteoarthritis Pain Drugs from 2019 to 2021.
Chapter 3, the Osteoarthritis Pain Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Osteoarthritis Pain Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Osteoarthritis Pain Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Osteoarthritis Pain Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Osteoarthritis Pain Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Osteoarthritis Pain Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market Analysis by Application
1.3.1 Overview: Global Osteoarthritis Pain Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Osteoarthritis Pain Drugs Market Size & Forecast
1.4.1 Global Osteoarthritis Pain Drugs Sales in Value (2016-2026))
1.4.2 Global Osteoarthritis Pain Drugs Sales in Volume (2016-2026)
1.4.3 Global Osteoarthritis Pain Drugs Price by Type (2016-2026) & (US$/Dose)
1.5 Global Osteoarthritis Pain Drugs Production Capacity Analysis
1.5.1 Global Osteoarthritis Pain Drugs Total Production Capacity (2016-2026)
1.5.2 Global Osteoarthritis Pain Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Osteoarthritis Pain Drugs Market Drivers
1.6.2 Osteoarthritis Pain Drugs Market Restraints
1.6.3 Osteoarthritis Pain Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Osteoarthritis Pain Drugs Product and Services
2.1.4 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Osteoarthritis Pain Drugs Product and Services
2.2.4 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 SK Chemicals
2.3.1 SK Chemicals Details
2.3.2 SK Chemicals Major Business
2.3.3 SK Chemicals Osteoarthritis Pain Drugs Product and Services
2.3.4 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Osteoarthritis Pain Drugs Product and Services
2.4.4 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Osteoarthritis Pain Drugs Product and Services
2.5.4 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Crystal Genomics
2.6.1 Crystal Genomics Details
2.6.2 Crystal Genomics Major Business
2.6.3 Crystal Genomics Osteoarthritis Pain Drugs Product and Services
2.6.4 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Product and Services
2.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sino Biopharmaceutical
2.8.1 Sino Biopharmaceutical Details
2.8.2 Sino Biopharmaceutical Major Business
2.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product and Services
2.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Haohai Biological
2.9.1 Haohai Biological Details
2.9.2 Haohai Biological Major Business
2.9.3 Haohai Biological Osteoarthritis Pain Drugs Product and Services
2.9.4 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Zhejiang Chengyi Pharmaceutical
2.10.1 Zhejiang Chengyi Pharmaceutical Details
2.10.2 Zhejiang Chengyi Pharmaceutical Major Business
2.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Freda
2.11.1 Freda Details
2.11.2 Freda Major Business
2.11.3 Freda Osteoarthritis Pain Drugs Product and Services
2.11.4 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Bright Future
2.12.1 Bright Future Details
2.12.2 Bright Future Major Business
2.12.3 Bright Future Osteoarthritis Pain Drugs Product and Services
2.12.4 Bright Future Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Jingfeng Pharmaceutical
2.13.1 Jingfeng Pharmaceutical Details
2.13.2 Jingfeng Pharmaceutical Major Business
2.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Chugai Pharmaceutical
2.14.1 Chugai Pharmaceutical Details
2.14.2 Chugai Pharmaceutical Major Business
2.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Mikasa Seiyaku
2.15.1 Mikasa Seiyaku Details
2.15.2 Mikasa Seiyaku Major Business
2.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Product and Services
2.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Taisho Pharmaceutical
2.16.1 Taisho Pharmaceutical Details
2.16.2 Taisho Pharmaceutical Major Business
2.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Seikagaku Corporation
2.17.1 Seikagaku Corporation Details
2.17.2 Seikagaku Corporation Major Business
2.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Product and Services
2.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 GlaxoSmithKline
2.18.1 GlaxoSmithKline Details
2.18.2 GlaxoSmithKline Major Business
2.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Product and Services
2.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Eli Lilly
2.19.1 Eli Lilly Details
2.19.2 Eli Lilly Major Business
2.19.3 Eli Lilly Osteoarthritis Pain Drugs Product and Services
2.19.4 Eli Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis Osteoarthritis Pain Drugs Product and Services
2.20.4 Novartis Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Horizon Pharma
2.21.1 Horizon Pharma Details
2.21.2 Horizon Pharma Major Business
2.21.3 Horizon Pharma Osteoarthritis Pain Drugs Product and Services
2.21.4 Horizon Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Abbott
2.22.1 Abbott Details
2.22.2 Abbott Major Business
2.22.3 Abbott Osteoarthritis Pain Drugs Product and Services
2.22.4 Abbott Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Mylan
2.23.1 Mylan Details
2.23.2 Mylan Major Business
2.23.3 Mylan Osteoarthritis Pain Drugs Product and Services
2.23.4 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Daiichi Sankyo
2.24.1 Daiichi Sankyo Details
2.24.2 Daiichi Sankyo Major Business
2.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Product and Services
2.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 TEVA
2.25.1 TEVA Details
2.25.2 TEVA Major Business
2.25.3 TEVA Osteoarthritis Pain Drugs Product and Services
2.25.4 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Almatica Pharma
2.26.1 Almatica Pharma Details
2.26.2 Almatica Pharma Major Business
2.26.3 Almatica Pharma Osteoarthritis Pain Drugs Product and Services
2.26.4 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.27 Astellas Pharma
2.27.1 Astellas Pharma Details
2.27.2 Astellas Pharma Major Business
2.27.3 Astellas Pharma Osteoarthritis Pain Drugs Product and Services
2.27.4 Astellas Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.28 Tide Pharmaceutical
2.28.1 Tide Pharmaceutical Details
2.28.2 Tide Pharmaceutical Major Business
2.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.29 Iroko Pharmaceuticals
2.29.1 Iroko Pharmaceuticals Details
2.29.2 Iroko Pharmaceuticals Major Business
2.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product and Services
2.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.30 Hengrui Pharmaceutical
2.30.1 Hengrui Pharmaceutical Details
2.30.2 Hengrui Pharmaceutical Major Business
2.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product and Services
2.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Osteoarthritis Pain Drugs Sales by Manufacturer
3.1 Global Osteoarthritis Pain Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Osteoarthritis Pain Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Osteoarthritis Pain Drugs Manufacturer Market Share
3.4.2 Top 6 Osteoarthritis Pain Drugs Manufacturer Market Share
3.5 Global Osteoarthritis Pain Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Osteoarthritis Pain Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Osteoarthritis Pain Drugs Market Size by Region
4.1.1 Global Osteoarthritis Pain Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Osteoarthritis Pain Drugs Revenue by Region (2016-2026)
4.2 North America Osteoarthritis Pain Drugs Revenue (2016-2026)
4.3 Europe Osteoarthritis Pain Drugs Revenue (2016-2026)
4.4 Asia-Pacific Osteoarthritis Pain Drugs Revenue (2016-2026)
4.5 South America Osteoarthritis Pain Drugs Revenue (2016-2026)
4.6 Middle East and Africa Osteoarthritis Pain Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Osteoarthritis Pain Drugs Sales in Volume by Type (2016-2026)
5.2 Global Osteoarthritis Pain Drugs Revenue by Type (2016-2026)
5.3 Global Osteoarthritis Pain Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Osteoarthritis Pain Drugs Sales in Volume by Application (2016-2026)
6.2 Global Osteoarthritis Pain Drugs Revenue by Application (2016-2026)
6.3 Global Osteoarthritis Pain Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Osteoarthritis Pain Drugs Sales by Type (2016-2026)
7.2 North America Osteoarthritis Pain Drugs Sales by Application (2016-2026)
7.3 North America Osteoarthritis Pain Drugs Market Size by Country
7.3.1 North America Osteoarthritis Pain Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Osteoarthritis Pain Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Osteoarthritis Pain Drugs Sales by Type (2016-2026)
8.2 Europe Osteoarthritis Pain Drugs Sales by Application (2016-2026)
8.3 Europe Osteoarthritis Pain Drugs Market Size by Country
8.3.1 Europe Osteoarthritis Pain Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Osteoarthritis Pain Drugs Market Size by Region
9.3.1 Asia-Pacific Osteoarthritis Pain Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Osteoarthritis Pain Drugs Sales by Type (2016-2026)
10.2 South America Osteoarthritis Pain Drugs Sales by Application (2016-2026)
10.3 South America Osteoarthritis Pain Drugs Market Size by Country
10.3.1 South America Osteoarthritis Pain Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Osteoarthritis Pain Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Osteoarthritis Pain Drugs Market Size by Country
11.3.1 Middle East & Africa Osteoarthritis Pain Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Osteoarthritis Pain Drugs Typical Distributors
12.3 Osteoarthritis Pain Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Osteoarthritis Pain Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Osteoarthritis Pain Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Osteoarthritis Pain Drugs Product and Services
Table 6. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Osteoarthritis Pain Drugs Product and Services
Table 10. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. SK Chemicals Basic Information, Manufacturing Base and Competitors
Table 12. SK Chemicals Major Business
Table 13. SK Chemicals Osteoarthritis Pain Drugs Product and Services
Table 14. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GSK Basic Information, Manufacturing Base and Competitors
Table 16. GSK Major Business
Table 17. GSK Osteoarthritis Pain Drugs Product and Services
Table 18. GSK Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Osteoarthritis Pain Drugs Product and Services
Table 22. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Crystal Genomics Basic Information, Manufacturing Base and Competitors
Table 24. Crystal Genomics Major Business
Table 25. Crystal Genomics Osteoarthritis Pain Drugs Product and Services
Table 26. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Osteoarthritis Pain Drugs Product and Services
Table 30. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sino Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Sino Biopharmaceutical Major Business
Table 33. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 34. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Haohai Biological Basic Information, Manufacturing Base and Competitors
Table 36. Haohai Biological Major Business
Table 37. Haohai Biological Osteoarthritis Pain Drugs Product and Services
Table 38. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Zhejiang Chengyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Zhejiang Chengyi Pharmaceutical Major Business
Table 41. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 42. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Freda Basic Information, Manufacturing Base and Competitors
Table 44. Freda Major Business
Table 45. Freda Osteoarthritis Pain Drugs Product and Services
Table 46. Freda Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Bright Future Basic Information, Manufacturing Base and Competitors
Table 48. Bright Future Major Business
Table 49. Bright Future Osteoarthritis Pain Drugs Product and Services
Table 50. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Jingfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Jingfeng Pharmaceutical Major Business
Table 53. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 54. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Chugai Pharmaceutical Major Business
Table 57. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 58. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Mikasa Seiyaku Basic Information, Manufacturing Base and Competitors
Table 60. Mikasa Seiyaku Major Business
Table 61. Mikasa Seiyaku Osteoarthritis Pain Drugs Product and Services
Table 62. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Taisho Pharmaceutical Major Business
Table 65. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 66. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Seikagaku Corporation Basic Information, Manufacturing Base and Competitors
Table 68. Seikagaku Corporation Major Business
Table 69. Seikagaku Corporation Osteoarthritis Pain Drugs Product and Services
Table 70. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 72. GlaxoSmithKline Major Business
Table 73. GlaxoSmithKline Osteoarthritis Pain Drugs Product and Services
Table 74. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 76. Eli Lilly Major Business
Table 77. Eli Lilly Osteoarthritis Pain Drugs Product and Services
Table 78. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Osteoarthritis Pain Drugs Product and Services
Table 82. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Horizon Pharma Major Business
Table 85. Horizon Pharma Osteoarthritis Pain Drugs Product and Services
Table 86. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Abbott Basic Information, Manufacturing Base and Competitors
Table 88. Abbott Major Business
Table 89. Abbott Osteoarthritis Pain Drugs Product and Services
Table 90. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Mylan Basic Information, Manufacturing Base and Competitors
Table 92. Mylan Major Business
Table 93. Mylan Osteoarthritis Pain Drugs Product and Services
Table 94. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 96. Daiichi Sankyo Major Business
Table 97. Daiichi Sankyo Osteoarthritis Pain Drugs Product and Services
Table 98. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. TEVA Basic Information, Manufacturing Base and Competitors
Table 100. TEVA Major Business
Table 101. TEVA Osteoarthritis Pain Drugs Product and Services
Table 102. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Almatica Pharma Major Business
Table 105. Almatica Pharma Osteoarthritis Pain Drugs Product and Services
Table 106. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 108. Astellas Pharma Major Business
Table 109. Astellas Pharma Osteoarthritis Pain Drugs Product and Services
Table 110. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Tide Pharmaceutical Major Business
Table 113. Tide Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 114. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 115. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Iroko PharmaceuticalsMajor Business
Table 117. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product and Services
Table 118. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 119. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 120. Hengrui Pharmaceutical Major Business
Table 121. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product and Services
Table 122. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 123. Global Osteoarthritis Pain Drugs Sales by Manufacturer (2019-2021e) & (M Dose)
Table 124. Global Osteoarthritis Pain Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 125. Market Position of Manufacturers in Osteoarthritis Pain Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 126. Global Osteoarthritis Pain Drugs Production Capacity by Company, (M Dose): 2020 VS 2021
Table 127. Head Office and Osteoarthritis Pain Drugs Production Site of Key Manufacturer
Table 128. Osteoarthritis Pain Drugs New Entrant and Capacity Expansion Plans
Table 129. Osteoarthritis Pain Drugs Mergers & Acquisitions in the Past Five Years
Table 130. Global Osteoarthritis Pain Drugs Sales by Region (2016-2021e) & (M Dose)
Table 131. Global Osteoarthritis Pain Drugs Sales by Region (2021-2026) & (M Dose)
Table 132. Global Osteoarthritis Pain Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 133. Global Osteoarthritis Pain Drugs Revenue by Region (2021-2026) & (USD Million)
Table 134. Global Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 135. Global Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 136. Global Osteoarthritis Pain Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 137. Global Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (USD Million)
Table 138. Global Osteoarthritis Pain Drugs Price by Type (2016-2021e) & (US$/Dose)
Table 139. Global Osteoarthritis Pain Drugs Price by Type (2021-2026) & (US$/Dose)
Table 140. Global Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 141. Global Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 142. Global Osteoarthritis Pain Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 143. Global Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (USD Million)
Table 144. Global Osteoarthritis Pain Drugs Price by Application (2016-2021e) & (US$/Dose)
Table 145. Global Osteoarthritis Pain Drugs Price by Application (2021-2026) & (US$/Dose)
Table 146. North America Osteoarthritis Pain Drugs Sales by Country (2016-2021e) & (M Dose)
Table 147. North America Osteoarthritis Pain Drugs Sales by Country (2021-2026) & (M Dose)
Table 148. North America Osteoarthritis Pain Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 149. North America Osteoarthritis Pain Drugs Revenue by Country (2021-2026) & (USD Million)
Table 150. North America Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 151. North America Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 152. North America Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 153. North America Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 154. Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021e) & (M Dose)
Table 155. Europe Osteoarthritis Pain Drugs Sales by Country (2021-2026) & (M Dose)
Table 156. Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 157. Europe Osteoarthritis Pain Drugs Revenue by Country (2021-2026) & (USD Million)
Table 158. Europe Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 159. Europe Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 160. Europe Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 161. Europe Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 162. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2016-2021e) & (M Dose)
Table 163. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2021-2026) & (M Dose)
Table 164. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 165. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2021-2026) & (USD Million)
Table 166. Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 167. Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 168. Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 169. Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 170. South America Osteoarthritis Pain Drugs Sales by Country (2016-2021e) & (M Dose)
Table 171. South America Osteoarthritis Pain Drugs Sales by Country (2021-2026) & (M Dose)
Table 172. South America Osteoarthritis Pain Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 173. South America Osteoarthritis Pain Drugs Revenue by Country (2021-2026) & (USD Million)
Table 174. South America Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 175. South America Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 176. South America Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 177. South America Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 178. Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021e) & (M Dose)
Table 179. Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2021-2026) & (M Dose)
Table 180. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 181. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2021-2026) & (USD Million)
Table 182. Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2016-2021e) & (M Dose)
Table 183. Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2021-2026) & (M Dose)
Table 184. Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2016-2021e) & (M Dose)
Table 185. Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2021-2026) & (M Dose)
Table 186. Direct Channel Pros & Cons
Table 187. Indirect Channel Pros & Cons
Table 188. Osteoarthritis Pain Drugs Typical Distributors
Table 189. Osteoarthritis Pain Drugs Typical Customers
List of Figures
Figure 1. Osteoarthritis Pain Drugs Picture
Figure 2. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. External
Figure 6. Global Osteoarthritis Pain Drugs Sales Market Share by Application in 2020
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Osteoarthritis Pain Drugs Market Size, (USD Million) & (M Dose): 2020 VS 2021 VS 2026
Figure 10. Global Osteoarthritis Pain Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Osteoarthritis Pain Drugs Sales (2016-2026) & (M Dose)
Figure 12. Global Osteoarthritis Pain Drugs Price by Type (2016-2026) & (US$/Dose)
Figure 13. Global Osteoarthritis Pain Drugs Production Capacity (2016-2026) & (M Dose)
Figure 14. Global Osteoarthritis Pain Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Osteoarthritis Pain Drugs Market Drivers
Figure 16. Osteoarthritis Pain Drugs Market Restraints
Figure 17. Osteoarthritis Pain Drugs Market Trends
Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturer in 2020
Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturer in 2020
Figure 20. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Osteoarthritis Pain Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2026)
Figure 24. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2026)
Figure 25. North America Osteoarthritis Pain Drugs Revenue (2016-2026) & (USD Million)
Figure 26. Europe Osteoarthritis Pain Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Osteoarthritis Pain Drugs Revenue (2016-2026) & (USD Million)
Figure 28. South America Osteoarthritis Pain Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Osteoarthritis Pain Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2026)
Figure 31. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2026)
Figure 32. Global Osteoarthritis Pain Drugs Price by Type (2016-2026) & (US$/Dose)
Figure 33. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 34. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2026)
Figure 35. Global Osteoarthritis Pain Drugs Price by Application (2016-2026) & (US$/Dose)
Figure 36. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2026)
Figure 37. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 38. North America Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2026)
Figure 39. North America Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2026)
Figure 40. United States Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2026)
Figure 44. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 45. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2026)
Figure 46. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2026)
Figure 47. Germany Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2026)
Figure 65. South America Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Osteoarthritis Pain Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---